# Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant

> **NCT05207618** · NA · COMPLETED · sponsor: **Hospital de Clinicas José de San Martín** · enrollment: 30 (actual)

## Conditions studied

- Irritable Bowel Syndrome
- Diarrhea

## Interventions

- **DIETARY_SUPPLEMENT:** ARBOX (QUEBRACHO AND CHESNUT EXTRACT)

## Key facts

- **NCT ID:** NCT05207618
- **Lead sponsor:** Hospital de Clinicas José de San Martín
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-21
- **Primary completion:** 2022-02-20
- **Final completion:** 2022-04-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05207618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05207618, "Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05207618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*